| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.71M | 18.54M | 12.66M | 19.03M | 18.16M | 13.66M |
| Gross Profit | 5.60M | 5.31M | 2.78M | 4.15M | 3.97M | 2.74M |
| EBITDA | -978.35K | -2.02M | -3.24M | -1.77M | -1.86M | -1.57M |
| Net Income | -559.22K | -1.37M | -2.82M | -1.32M | -3.12M | -1.80M |
Balance Sheet | ||||||
| Total Assets | 40.27M | 41.28M | 42.84M | 48.19M | 50.98M | 51.72M |
| Cash, Cash Equivalents and Short-Term Investments | 30.73M | 32.20M | 33.28M | 25.86M | 42.23M | 41.98M |
| Total Debt | 85.75K | 237.79K | 584.36K | 819.47K | 1.08M | 1.31M |
| Total Liabilities | 1.65M | 1.94M | 1.87M | 3.14M | 3.18M | 2.25M |
| Stockholders Equity | 38.62M | 39.35M | 40.97M | 45.06M | 47.80M | 49.47M |
Cash Flow | ||||||
| Free Cash Flow | -162.69K | 236.11K | -1.31M | -5.17M | 94.09K | -21.37K |
| Operating Cash Flow | 458.34K | 1.10M | 316.99K | -4.90M | 474.07K | 226.78K |
| Investing Cash Flow | 3.22M | 3.47M | 2.00M | -31.15M | 24.69M | 9.75M |
| Financing Cash Flow | -1.98M | -1.73M | -2.27M | -1.51M | 474.28K | -1.43M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
54 Neutral | C$1.19B | -126.76 | -87.47% | ― | 331.08% | 15.77% | |
53 Neutral | C$136.50M | -16.67 | -92.59% | ― | 6.29% | -3.71% | |
51 Neutral | C$252.00M | -311.59 | -2.11% | ― | 30.76% | 52.23% | |
50 Neutral | C$115.66M | -20.70 | -2.95% | 3.41% | 5.06% | 93.02% | |
50 Neutral | C$702.19M | -48.34 | -1.61% | 2.35% | 8.04% | -195.66% | |
45 Neutral | C$183.97M | -16.79 | -64.59% | ― | ― | 56.03% |
EcoSynthetix Inc. recently held its earnings call, presenting a generally positive outlook with notable sales growth and market diversification. The company has made significant strides in the pulp and tissue markets, as well as progress in wood composites and personal care sectors. Despite some concerns about declining gross profit percentages and increased SG&A expenses, EcoSynthetix’s strategic market positioning and operational efficiencies suggest strong potential for future growth.
EcoSynthetix reported a 11% increase in net sales for Q3 2025, driven by higher volumes and new commercial accounts in Europe for its SurfLock™ strength aids. The company maintained a strong balance sheet with $30.4 million in cash and term deposits, and is positioned for long-term growth with strategic partnerships in key markets.
The most recent analyst rating on (TSE:ECO) stock is a Hold with a C$4.50 price target. To see the full list of analyst forecasts on EcoSynthetix stock, see the TSE:ECO Stock Forecast page.
EcoSynthetix Inc. has secured two new tissue line contracts in Europe for its bio-based strength aid, SurfLock™, through a partnership with RNM Group. This development highlights the growing recognition of SurfLock™’s value in strengthening paper applications while using cost-effective or recycled materials, enhancing EcoSynthetix’s market position and expanding its reach in the tissue industry.
The most recent analyst rating on (TSE:ECO) stock is a Hold with a C$4.00 price target. To see the full list of analyst forecasts on EcoSynthetix stock, see the TSE:ECO Stock Forecast page.